{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:23:04Z","timestamp":1786990984109,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20190201047JC"],"award-info":[{"award-number":["20190201047JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20200201482JC"],"award-info":[{"award-number":["20200201482JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.intimp.2022.108729","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T07:27:04Z","timestamp":1648279624000},"page":"108729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Overexpression of ascitic interleukin-35 induces CD8+ T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis"],"prefix":"10.1016","volume":"108","author":[{"given":"Lanlan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.108729_b0005","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2022.108729_b0010","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/1389450117666160613101413","article-title":"Recent advancements in diagnosis and therapy of liver cirrhosis","volume":"17","author":"Romanelli","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.intimp.2022.108729_b0015","first-page":"759","article-title":"Cirrhosis: diagnosis and management","volume":"100","author":"Smith","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.intimp.2022.108729_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.608498","article-title":"Toll-like receptors recognize intestinal microbes in liver cirrhosis","volume":"12","author":"Fan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2022.108729_b0025","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3748\/wjg.v25.i15.1817","article-title":"Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients","volume":"25","author":"Kamimura","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2022.108729_b0030","first-page":"91","article-title":"Infections in patients affected by liver cirrhosis: an update","volume":"25","author":"Ascione","year":"2017","journal-title":"Infez Med."},{"key":"10.1016\/j.intimp.2022.108729_b0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2022.108729_b0040","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.13172","article-title":"Review article: spontaneous bacterial peritonitis\u2013bacteriology, diagnosis, treatment, risk factors and prevention","volume":"41","author":"Dever","year":"2015","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2022.108729_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2019.00069","article-title":"Compartmentalization of immune response and microbial translocation in decompensated cirrhosis","volume":"10","author":"Alvarez-Silva","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2022.108729_b0055","doi-asserted-by":"crossref","first-page":"7537649","DOI":"10.1155\/2019\/7537649","article-title":"Immune dysfunction and albumin-related immunity in liver cirrhosis","volume":"2019","author":"Wilde","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2022.108729_b0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2022.108729_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.intimp.2017.06.015","article-title":"An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection","volume":"50","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.108729_b0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fcimb.2017.00472","article-title":"Interleukin-35 suppresses antiviral immune response in chronic Hepatitis B virus infection","volume":"7","author":"Shao","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.intimp.2022.108729_b0075","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1007\/s10620-020-06077-w","article-title":"Interleukin-35 suppresses CD8(+) T cell activity in patients with viral hepatitis-induced acute-on-chronic liver failure","volume":"65","author":"Yang","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2022.108729_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108161","article-title":"Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma","volume":"100","author":"Liu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.108729_b0085","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fimmu.2019.01032","article-title":"Interleukin-35 Dampens CD8(+) T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0090","article-title":"Interleukin-35 suppresses interleukin-9-secreting CD4(+) T cell activity in patients with Hepatitis B-related hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2022.108729_b0100","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3389\/fimmu.2019.00988","article-title":"The IL-12 cytokine and receptor family in graft-vs.-host disease","volume":"10","author":"Bastian","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2022.108729_b0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12865-020-00348-x","article-title":"Increased Interleukin-35 suppresses peripheral CD14(+) monocytes function in patients with Kawasaki disease","volume":"21","author":"Xing","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0120","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jcb.29441","article-title":"IL-35, a double-edged sword in cancer","volume":"121","author":"Yazdani","year":"2020","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.intimp.2022.108729_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.13044","article-title":"Interleukin-35 in immune-related diseases: protection or destruction","volume":"157","author":"Zhang","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2022.108729_b0130","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","article-title":"Non-invasive diagnosis of liver fibrosis and cirrhosis","volume":"21","author":"Lurie","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2022.108729_b0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2022.108729_b0140","first-page":"45","article-title":"mRNA Expressions of T-bet, GATA-3, ROR gammat and Foxp3 in peripheral blood of patients with chronic lymphocytic leukemia in different stages","volume":"23","author":"Yu","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.intimp.2022.108729_b0145","doi-asserted-by":"crossref","unstructured":"S. Boegel, M. Lower, T. Bukur, U. Sahin, J.C. Castle, A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines, Oncoimmunology 3 (2014) e954893.","DOI":"10.4161\/21624011.2014.954893"},{"key":"10.1016\/j.intimp.2022.108729_b0150","article-title":"The role of IL-35 in the pathophysiological processes of liver disease","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108729_b0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-020-08803-8","article-title":"Interleukin-35 promotes Th9 cell differentiation in IgG4-related disorders: experimental data and review of the literature","volume":"60","author":"Zhang","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0160","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.21037\/apm-21-1680","article-title":"Lower levels of interleukin-35 in patients with prophase of liver failure are associated with progression to liver failure","volume":"10","author":"Chen","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.intimp.2022.108729_b0165","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.3389\/fimmu.2019.02577","article-title":"Interleukin-35 regulates immune microenvironment of autoimmune hepatitis through inducing the expansion of myeloid-derived suppressor cells","volume":"10","author":"Lian","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0170","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3389\/fphar.2018.00959","article-title":"Interleukin-35 attenuates D-galactosamine\/lipopolysaccharide-induced liver injury via enhancing Interleukin-10 production in Kupffer cells","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.intimp.2022.108729_b0175","doi-asserted-by":"crossref","first-page":"45678","DOI":"10.18632\/oncotarget.10141","article-title":"IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression","volume":"7","author":"Long","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2022.108729_b0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.13535","article-title":"Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma","volume":"203","author":"Liu","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1620\/tjem.244.123","article-title":"Lower plasma levels of IL-35 in patients with primary biliary cirrhosis","volume":"244","author":"Li","year":"2018","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.intimp.2022.108729_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.55133\/eji.280105","article-title":"Regulatory T cells and IL35 in chronic Hepatitis C related cirrhosis and hepatocellular carcinoma","volume":"28","author":"Abd El-Ghani","year":"2021","journal-title":"Egypt J. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/mmr.2014.2681","article-title":"Function of interleukin-17 and -35 in the blood of patients with hepatitis B-related liver cirrhosis","volume":"11","author":"Shi","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2022.108729_b0200","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3892\/ijmm.2014.1662","article-title":"Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension","volume":"33","author":"Wang","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2022.108729_b0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2015.08.016","article-title":"IL-35 is elevated in clinical and experimental sepsis and mediates inflammation","volume":"161","author":"Cao","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.108729_b0210","doi-asserted-by":"crossref","first-page":"13212","DOI":"10.1038\/s41598-020-69984-y","article-title":"Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1\/Th17 and upregulation of Foxp3(+)Treg","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2022.108729_b0215","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108729_b0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.intimp.2022.108729_b0225","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/jvh.13370","article-title":"Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8(+) T cells after direct-acting antiviral therapies","volume":"27","author":"Perpinan","year":"2020","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.intimp.2022.108729_b0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4049\/jimmunol.0902761","article-title":"CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions","volume":"184","author":"Phillips","year":"2010","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:36:46Z","timestamp":1761586606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922002132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":46,"alternative-id":["S1567576922002132"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108729","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of ascitic interleukin-35 induces CD8+ T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108729"}}